SPRING MILL PHARMA INCORPORATED
SPRING MILL PHARMA INCORPORATED Grant
SPRING MILL PHARMA INCORPORATED Grant is a funding opportunity from SPRING MILL PHARMA INCORPORATED, up to 1103779, closing April 30, 2027.
Apr 30, 2027
(273d left)Overview
PROJECT SUMMARY Carbapenem-resistance in Enterobacterales has steadily increased over the past decade, leading to multidrug and pan-drug resistance (MDR/PDR), further emphasizing the need for new innovative therapies. Carbapenem- resistant Enterobacterales (CRE) is a serious global health problem classified by the US…